- Home
- BBWI vs RVMD Comparison
BBWI vs RVMD Comparison
Compare BBWI & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBWI
- RVMD
- Stock Information
- Founded
- BBWI 1963
- RVMD 2014
- Country
- BBWI United States
- RVMD United States
- Employees
- BBWI N/A
- RVMD N/A
- Industry
- BBWI Clothing/Shoe/Accessory Stores
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BBWI Consumer Discretionary
- RVMD Health Care
- Exchange
- BBWI Nasdaq
- RVMD Nasdaq
- Market Cap
- BBWI 8.2B
- RVMD 8.7B
- IPO Year
- BBWI N/A
- RVMD 2020
- Fundamental
- Price
- BBWI $30.54
- RVMD $37.29
- Analyst Decision
- BBWI Buy
- RVMD Strong Buy
- Analyst Count
- BBWI 18
- RVMD 13
- Target Price
- BBWI $44.94
- RVMD $67.77
- AVG Volume (30 Days)
- BBWI 7.0M
- RVMD 1.3M
- Earning Date
- BBWI 02-27-2025
- RVMD 05-07-2025
- Dividend Yield
- BBWI 2.58%
- RVMD N/A
- EPS Growth
- BBWI N/A
- RVMD N/A
- EPS
- BBWI 3.61
- RVMD N/A
- Revenue
- BBWI $7,307,000,000.00
- RVMD N/A
- Revenue This Year
- BBWI $4.87
- RVMD N/A
- Revenue Next Year
- BBWI $3.08
- RVMD $153.09
- P/E Ratio
- BBWI $8.57
- RVMD N/A
- Revenue Growth
- BBWI N/A
- RVMD N/A
- 52 Week Low
- BBWI $26.21
- RVMD $29.55
- 52 Week High
- BBWI $52.99
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- BBWI 41.05
- RVMD 42.92
- Support Level
- BBWI $29.21
- RVMD $37.42
- Resistance Level
- BBWI $32.76
- RVMD $39.59
- Average True Range (ATR)
- BBWI 1.38
- RVMD 1.32
- MACD
- BBWI 0.32
- RVMD 0.05
- Stochastic Oscillator
- BBWI 61.51
- RVMD 29.10
About BBWI Bath & Body Works Inc.
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2023. For fiscal 2023, 74% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2022 levels, as consumer shopping patterns remained to normal. Future growth is expected from store reformatting, digital and international channels, as well as adjacent category expansions like hair and laundry.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.